| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |